Search Results - "Jones, C.U."

Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522 by Yao, M, Zhang, Q, Woods, C.R, Nguyen-Tan, P.F, Rosenthal, D.I, Garden, A.S, Thorstad, W.L, Anne, P.R, Schultz, C.J, Caudell, J.J, Filion, E, Ridge, J.A, Jones, C.U, Kim, H, Yom, S.S, Raben, D, Bonner, J.A, Machtay, M, Harris, J, Le, Q.T

Get full text

Radiation Therapy Oncology Group (RTOG) 9408: A Secondary Analysis of the Risk of Death From Second Cancers Comparing Whole Pelvic (WP) Radiation Therapy (RT) to Prostate Only (PO) RT and Neoadjuvant Hormonal Therapy (NHT) + RT to RT Alone by Roach, M, Hunt, D, Jones, C.U, Bahary, J, Zeitzer, K.L, Souhami, L, Leibenhaut, M.H, Rotman, M, Gore, E.M, Sandler, H.M

Get full text

Serum Testosterone Changes in Patients Treated With Radiation Therapy Alone for Prostate Cancer on RTOG 9408 by Nichols, R, George, A, Bahary, J, Zeitzer, K.L, Souhami, L, Leibenhaut, M.H, Rotman, M, Gore, E.M, Balogh, A.G, Jones, C.U

Get full text

RTOG 90-03: Final Report by Beitler, J.J, Zhang, Q, Fu, K.K, Trotti, A, Spencer, S.A, Jones, C.U, Garden, A.S, Shenouda, G, Harris, J, Ang, K.K

Get full text

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury by Mak, R.H, Hunt, D, Shipley, W.U, Jones, C.U, Lukka, H.R, Bahary, J.P, Souhami, L, Husain, S, Efstathiou, J.A, Sandler, H.M

Get full text

Ki-67 Staining is a Strong Predictor of Patient Outcomes for Prostate Cancer Patients Treated on RTOG 94-08 by Ritter, M.A, Yan, Y, Verhoven, B, Khor, L, Hammond, E, Jones, C.U, Amin, M.B, Bahary, J, Zeitzer, K.L, Pollack, A

Get full text

Cardiovascular Mortality following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08 by Efstathiou, J.A, Paulus, R, Smith, M.R, Jones, C.U, Leibenhaut, M.H, Husain, S.M, Rotman, M, Souhami, L, Sandler, H.M, Shipley, W.U

Get full text

Should Hypopharynx Cancer Continue to be Included in ‘Multi-head and Neck’ Trials within the RTOG? by Den, R.B, Zhang, Q, Cognetti, D, Machtay, M, Cooper, J.S, Garden, A.S, Jones, C.U, Yom, S, Ang, K.K

Get full text

Short-term Endocrine Therapy Prior to and during Radiation Therapy Improves Overall Survival in Patients with T1b-T2b Adenocarcinoma of the Prostate and PSA ≤ 20: Initial Results of RTOG 94-08 by McGowan, D.G, Hunt, D, Jones, C.U, Amin, M, Leibenhaut, M.H, Husian, S.M, Rotman, M, Souhami, L, Sandler, H, Shipley, W.U

Get full text

Results of Radiation Therapy Oncology Group 97-03—A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long-term Results and Late Toxicities by Garden, A.S, Harris, J, Vokes, E.E, Forastiere, A.A, Ridge, J.A, Jones, C.U, Horowitz, E.M, Glisson, B.S, Nabell, L, Cooper, J.S

Get full text

Chromosomal Instability as a Prognostic Biomarker for Local Failure in Laryngeal Carcinoma Patients Treated with Definitive Radiation in NRG/RTOG 9512 by Cosper, P., Harris, J., Jones, K., Bryan, A., Paracha, M., Henderson, L., Hu, R., Jr, P.M. Harari, Emami, B., Sagar, S.M., Firat, S., Caudell, J., Ma, D.J., Jones, C.U., Garg, M.K., Feigenberg, S.J., Galloway, T.J., Kim, H.E., Le, Q.T.

“…Chromosomal instability (CIN) is an ongoing rate of chromosome missegregation events over the course of multiple cell divisions and is common in cancer. There…”
Get full text

Metrics Derived from Architecture of Tumor-Infiltrating Lymphocytes are Associated with Overall Survival in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Patients: Results from NRG/RTOG 0129 and 0522 by Corredor, G., Harris, J., Koyuncu, C., Pathak, T., Pandav, K., Toro, P., Yang, K., Faraji, F., Castro, P., Sandulache, V.C., Koyfman, S.A., Nguyen, F., Garden, A.S., Caudell, J.J., Jones, C.U., Rosenthal, D.I., Le, Q.T., Lewis, J.S., Madabhushi, A.

“…Subsets of patients (pts) with HPV-positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) treated with standard therapies experience poor survival…”
Get full text

Surrogate Endpoints in p16-Positive Squamous Cell Carcinoma of the Oropharynx by Gharzai, L.A., Morris, E., Nguyen-Tan, P.F., Rosenthal, D.I., Gillison, M., Harari, P.M., Garden, A.S., Zanotti, K., Caudell, J.J., Jones, C.U., Mitchell, D.L., Krempl, G.A., Ridge, J.A., Gensheimer, M.F., Bonner, J.A., Le, Q.T., Torres-Saavedra, P., Mierzwa, M.L., Schipper, M.

“…The increased incidence of HPV-related cancers has motivated efforts to optimize treatment paradigms for these excellent-prognosis patients. Validation of…”
Get full text

Gastrostomy Tube Use in Head and Neck Cancer Survivors, Pre-Treatment Factors Supersede Treatment Intensification: A Second Analysis of RTOG 0129, RTOG 0522, and NRG/RTOG 1016 by Galloway, T.J., DeMora, L., Ridge, J.A., Nguyen-Tan, P.F., Rosenthal, D.I., Gillison, M., Garden, A.S., Dunlap, N.E., Caudell, J.J., Jones, C.U., Bauman, J.R., Bahig, H., Shenouda, G., Currey, A.D., Koyfman, S.A., Stokes, W.A., Read, N.E., Pugh, S., Le, Q.T.

Get full text

655MO Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy (RT) with either cisplatin or cetuximab in NRG/RTOG 1016 by Ringash, J., DeMora, L., Gillison, M.L., Adelstein, D.J., Harari, P., Sturgis, E.M., Basch, E.M., Koyfman, S.A., Krempl, G.A., Blakaj, D.M., Bates, J.E., Galloway, T., Jones, C.U., Beadle, B.M., Torres-Saavedra, P., Le, Q-T., Movsas, B.

Get full text

Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016 by Runge, C.L., Lyness, J., Gillison, M., Adelstein, D.J., Harari, P.M., Ringash, J.G., Geiger, J.L., Krempl, G.A., Blakaj, D., Bates, J., Galloway, T.J., Jones, C.U., Gensheimer, M., Dunlap, N.E., Phan, J., Caudell, J., Pennington, D., Torres-Saavedra, P., Yom, S.S., Le, Q.T., Movsas, B.

“…NRG/RTOG 1016 was a noninferiority phase 3 trial comparing the efficacy of radiation with either cisplatin (RT+Cisp) or cetuximab (RT+Cetux) for patients with…”
Get full text

Association of Black Race With Improved Outcomes Following Definitive Radiotherapy With Androgen Deprivation Therapy for High-Risk Prostate Cancer: A Meta-Analysis of Eight Randomized Trials by Kishan, A.U., Romero, T., Rettig, M., Garraway, I., Roach, M., Pisansky, T.M., Michalski, J.M., Lee, W.R., Jones, C.U., Rosenthal, S.A., Feng, F.Y., Mahal, B.A., Dess, R.T., Nickols, N.G., Tran, P.T., Boutros, P., Steinberg, M.L., Elashoff, D.A., Sandler, H.M., Spratt, D.E.

Get full text

Effect Of Hormone Therapy Within Risk Groups Defined By Generalized Competing Event Model: Ancillary Analysis Of NRG Oncology’s RTOG 9408 by Mell, L.K., Pugh, S., Jones, C.U., Nelson, T.J., Morginstin, M., Gore, E.M., Zakeri, K., Bahary, J.P., Souhami, L., Michalski, J.M., Hartford, A.C., Mishra, M.V., Roach, M., Parliament, M.B., Choi, K.N., Pisansky, T.M., Husain, S.M., Malone, S., Horwitz, E.M., Feng, F.Y.

Get full text

863MO Nomogram for predicting survival for patients receiving definitive chemoradiation in locally advanced squamous cell carcinoma of the head and neck: A secondary analysis of NRG/RTOG 0129, 0522, and 1016 by Kharouta, M.Z., Patil, N., Torres-Saavedra, P., Wang, G-M., Damico, N., Deshane, A., Waite, K., Dorth, J., Yao, M., Machtay, M., Barnholtz-Sloan, J.S., Rosenthal, D.I., Dunlap, N., Caudell, J., Jones, C.U., Ridge, J.A., Nguyen-Tan, P.F., Stokes, W.A., Henson, C., Bhatt, A.

Get full text

NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer by Yom, S.S., Torres-Saavedra, P., Caudell, J.J., Waldron, J.N., Gillison, M.L., Truong, M.T., Jordan, R., Subramaniam, R., Yao, M., Chung, C., Geiger, J.L., Chan, J., O'Sullivan, B., Blakaj, D.M., Mell, L.K., Thorstad, W.L., Jones, C.U., Banerjee, R.N., Lominska, C.E., Le, Q.T.

Get full text